首页> 美国卫生研究院文献>Stem Cell Research Therapy >Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

【2h】

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

机译：纠正：仔细仔细治疗多发性骨髓瘤？ Car-T细胞是乐观的好理由

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Publisher's Note

机译：出版商的注意事项

著录项

期刊名称 Stem Cell Research Therapy
作者
Faroogh Marofi; Safa Tahmasebi; Heshu Sulaiman Rahman; Denis Kaigorodov; Alexander Markov; Alexei Valerievich Yumashev; Navid Shomali; Max Stanley Chartrand; Yashwant Pathak; Rebar N. Mohammed; Mostafa Jarahian; Roza Motavalli; Farhad Motavalli Khiavi;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 1
原文格式 PDF
正文语种
中图分类细胞生物学;医学史;
关键词

相似文献

外文文献
中文文献
专利

1. Successful Treatment of Relapsed/Refractory Extramedullary Multiple Myeloma With Anti-BCMA CAR-T Cell Therapy Followed by Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report and a Review of the Contemporary Literature [J] . Ying Qian, Zijun Qian, Xiujie Zhao, Frontiers in Medicine . 2021,第a期

机译：用抗BCMA Car-T细胞疗法的复发/难治性髓外骨髓瘤的成功治疗随后是Haploidentical造血干细胞移植：案例报告和对当代文学的审查
2. Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function [J] . Shao-long HE, Yu-hang CHENG, Di WANG, 当代医学科学(英文) . 2021,第003期

机译：Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
3. PRELIMINARY CLINICAL PHARMACOKINETIC ANALYSIS OF PHASE 1B/2 STUDY OF JNJ-4528 (BCMA CAR-T) CELL THERAPY IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA (R/R MM). [J] . Singh I., Zudaire E., Usmani S., Clinical Pharmacology and Therapeutics . 2020,第S1期

机译：初步临床药代动力学分析JNJ-4528（BCMA CAR-T）细胞治疗复发和/或难治性多发性骨髓瘤（R / R mm）的患者。
4. LEVERAGING BIOPROCESS PLATFORM TECHNOLOGY FOR THE DEVELOPMENT OF A ROBUST, SCALABLE, AND ECONOMIC MANUFACTURING PROCESS OF ALLOGENEIC CAR-T CELL THERAPY PRODUCTS [C] . Bernadette Dahlin Conference on advancing manufacture of cell and gene therapies . 2019

机译：充分利用生物过程平台技术开发鲁棒，可缩放且经济的异源CAR T细胞治疗产品生产过程
5. A Heavy-Chain-Only CAR-T Cell Therapy Elicits Comparable Antitumor Response Compared with Canonical CAR-T Cells [D] . Wang, Guanmeng . 2019

机译：与规范汽车-T细胞相比，仅重链的Cel-T细胞疗法引发了可比的抗肿瘤反应
6. Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism [O] . Faroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, 2021

机译：更接近多发性骨髓瘤的成功治疗？ Car-T细胞是乐观的好理由
7. Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism [O] . Faroogh Marofi, Safa Tahmasebi, Heshu Sulaiman Rahman, 2021

机译：更接近多发性骨髓瘤的成功治疗？ Car-T细胞是乐观的好理由

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

摘要

著录项

相似文献

相关主题

期刊订阅